Copmed Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in New Delhi, Delhi, India, established in 1988.
1988 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Copmed Pharmaceuticals Private Limited

Copmed Pharmaceuticals Private Limited, a active private limited company, was established on 13 September 1988 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1988PTC033151. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹9.60 M.

It upholds a compliant status. Employing 349 professional, Its leadership includes Abhay Kumar Srivastava (Director), Akhlas Ahmed (Director), Veer Singh Pal (Director). Past directors included Abhay Kumar Srivastava, Saroj Singh, Akhlas Ahmed. It holds ₹54.85 Cr open charges and ₹25.30 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 208, Okhla Industrial Estate, Phase-Iii, New Delhi, Delhi, 110020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1988PTC033151

  • Registration Number

    033151

  • Incorporation Date

    13 September 1988

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹9.60 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 9.60 M
  • Company Age 37 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 54.85 Cr
  • Satisfied Charges ₹ 25.30 Cr
  • Revenue Growth **** 30.23%
  • Profit Growth **** 60.03%
  • Ebitda **** 44.73%
  • Net Worth 23.30%
  • Total Assets **** 11.46%
Company report

Copmed Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Copmed Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Copmed Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Abhay Kumar Srivastava Director 01 Mar 2021 Current
Akhlas Ahmed Director 01 Mar 2021 Current
Veer Singh Pal Director 31 Jul 2009 Current
Jagmohan Sharma Whole-Time Director 08 Aug 2024 Current
Bhupendra Kaushik Director 26 Mar 2021 Current
Anju Kumari Jha Director 26 Mar 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 31 Jul 2009 Past
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 31 Jul 2009 Past
Pramod Abcsdd Director 31 Jul 2009 Past
Pramod Abcsdd Additional Director 21 Sep 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Copmed Pharmaceuticals.

Copmed Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 30.23% increase. The company also saw a substantial improvement in profitability, with a 60.03% increase in profit. The company's net worth Soared by an impressive increase of 23.3%.

Copmed Pharmaceuticals revenue growth over time
Copmed Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 30.23%
*******
*******
*******
*******
Revenue from Operations
*******
 29.07%
*******
*******
*******
*******
Total Assets
*******
 11.46%
*******
*******
*******
*******
Profit or Loss
*******
 60.03%
*******
*******
*******
*******
Net Worth
*******
 23.30%
*******
*******
*******
*******
EBITDA
*******
 44.73%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Copmed Pharmaceuticals?

In 2024, Copmed Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹548,509,111.00

Satisfied Charges

₹253,000,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 54.00 Cr
  • Others : 0.85 Cr
Latest Charge Details
Date Lender Amount Status
22 Sep 2021 Others ₹3.98 M Open
22 Sep 2021 Others ₹4.53 M Open
30 Sep 2010 Hdfc Bank Limited ₹54.00 Cr Open
30 Sep 2010 Hdfc Bank Limited ₹20.00 Cr Satisfied
05 Sep 2009 Member Secretary ₹3.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Copmed Pharmaceuticals?

Copmed Pharmaceuticals has a workforce of 349 employees as of May 21, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Copmed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Copmed Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Copmed Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Copmed Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Copmed Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Director Appointment

    The activity Jagmohan Sharma was appointed as a Whole-time director was appointed as a Whole-time director on 08 Aug 2024 & has been associated with this company since 1 year 6 months . was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 54.00 Cr registered on 30 Sep 2010 with Charge ID 10248378 was modified on 08 May 2023. was documented.

  • Charges

    A charge registered on 30 Sep 2010 via Charge ID 10248381 with Hdfc Bank Limited was fully satisfied on 05 Oct 2021. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 0.40 Cr with Charge ID 100481953 was registered on 22 Sep 2021. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Copmed Pharmaceuticals Private Limited?

The CIN of Copmed Pharmaceuticals Private Limited is U74899DL1988PTC033151.

Where is Copmed Pharmaceuticals Private Limited headquartered?

Copmed Pharmaceuticals Private Limited is headquartered at 208, Okhla Industrial Estate, Phase-Iii, New Delhi, Delhi, 110020.

When was Copmed Pharmaceuticals Private Limited incorporated?

Copmed Pharmaceuticals Private Limited was incorporated on 13 September 1988.

Who are the current directors of Copmed Pharmaceuticals Private Limited?

The current directors of Copmed Pharmaceuticals Private Limited are

What is the primary industry of Copmed Pharmaceuticals Private Limited?

The primary industry of Copmed Pharmaceuticals Private Limited is Manufacturing.

Is Copmed Pharmaceuticals Private Limited a listed company?

Copmed Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Copmed Pharmaceuticals Private Limited?

The authorized capital of Copmed Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹9.60 M.

What is the compliance status of Copmed Pharmaceuticals Private Limited?

The compliance status of Copmed Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available